Clinical Trial Update: The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 study of KN046 in combination with lenvatinib for advanced hepatocellular carcinoma has completed; results are not described in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• KN046
• LENVIMA (lenvatinib)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: HCC | Phase 2 | Status: COMPLETED